Hua Medicine ("the Company", Hong Kong Stock Exchange Stock Code: 2552.HK) announced today that its global first-in-class glucokinase activator (GKA) dorzagliatin (Trade name: MYHOMSIS®, 華領片®) has ...

A lengthier campaign risks sabotaging the euro zone’s fledgling revival while reawakening inflationary forces that the European Central Bank has fought hard to contain. A reliance on oil and gas from ...